Found: 16
Select item for more details and to access through your institution.
Technical note: A wearable radiation measurement system for collection of patient‐specific time‐activity data in radiopharmaceutical therapy: system design and Monte Carlo simulation results.
- Published in:
- Medical Physics, 2021, v. 48, n. 12, p. 8117, doi. 10.1002/mp.15311
- By:
- Publication type:
- Article
Impact of missing attenuation and scatter corrections on <sup>99m</sup>Tc‐MAA SPECT 3D dosimetry for liver radioembolization using the patient relative calibration methodology: A retrospective investigation on clinical images.
- Published in:
- Medical Physics, 2018, v. 45, n. 4, p. 1684, doi. 10.1002/mp.12774
- By:
- Publication type:
- Article
Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.
- Published in:
- Medical Physics, 2016, v. 43, n. 7, p. 4053, doi. 10.1118/1.4953203
- By:
- Publication type:
- Article
An analytical method for computing voxel S values for electrons and photons.
- Published in:
- Medical Physics, 2012, v. 39, n. 11, p. 6808, doi. 10.1118/1.4757912
- By:
- Publication type:
- Article
Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients.
- Published in:
- Translational Medicine Communications, 2020, v. 5, n. 1, p. 1, doi. 10.1186/s41231-020-00077-8
- By:
- Publication type:
- Article
Deep Seated Tumour Treatments With Electrons of High Energy Delivered at FLASH Rates: The Example of Prostate Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.777852
- By:
- Publication type:
- Article
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting Ra-dichloride.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 1, p. 21, doi. 10.1007/s00259-015-3150-2
- By:
- Publication type:
- Article
Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with Sm-EDTMP.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 2, p. 238, doi. 10.1007/s00259-013-2552-2
- By:
- Publication type:
- Article
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with <sup>90</sup>Y-ibritumomab tiuxetan (Zevalin).
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 5, p. 862, doi. 10.1007/s00259-009-1333-4
- By:
- Publication type:
- Article
The Essential Role of Monte Carlo Simulations for Lung Dosimetry in Liver Radioembolization with 90 Y Microspheres.
- Published in:
- Applied Sciences (2076-3417), 2024, v. 14, n. 17, p. 7684, doi. 10.3390/app14177684
- By:
- Publication type:
- Article
In Silico Validation of MCID Platform for Monte Carlo-Based Voxel Dosimetry Applied to 90 Y-Radioembolization of Liver Malignancies.
- Published in:
- Applied Sciences (2076-3417), 2021, v. 11, n. 4, p. 1939, doi. 10.3390/app11041939
- By:
- Publication type:
- Article
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with <sup>223</sup>Radium-dichloride.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/diagnostics12071763
- By:
- Publication type:
- Article
Dosimetry-Based Consideration on Remission and Relapse after Therapy with <sup>223</sup>Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Correlation of dose with toxicity and tumour response to <sup>90</sup>Y- and <sup>177</sup>Lu-PRRT provides the basis for optimization through individualized treatment planning.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 13, p. 2426, doi. 10.1007/s00259-018-4044-x
- By:
- Publication type:
- Article